Cargando…
Seizure reduction is a prognostic marker in low-grade glioma patients treated with temozolomide
We aimed to analyze the value of seizure reduction and radiological response as prognostic markers of survival in patients with low-grade glioma (LGG) treated with temozolomide (TMZ) chemotherapy. We retrospectively reviewed adult patients with a progressive LGG and uncontrolled epilepsy in two hosp...
Autores principales: | Koekkoek, Johan A. F., Dirven, Linda, Heimans, Jan J., Postma, Tjeerd J., Vos, Maaike J., Reijneveld, Jaap C., Taphoorn, Martin J. B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4718947/ https://www.ncbi.nlm.nih.gov/pubmed/26547911 http://dx.doi.org/10.1007/s11060-015-1975-y |
Ejemplares similares
-
Withdrawal of antiepileptic drugs in glioma patients after long-term seizure freedom: design of a prospective observational study
por: Koekkoek, Johan A F, et al.
Publicado: (2014) -
Antiepileptic drug treatment in the end-of-life phase of glioma patients: a feasibility study
por: Koekkoek, Johan A. F., et al.
Publicado: (2015) -
Health-related quality of life in high-grade glioma patients
por: Dirven, Linda, et al.
Publicado: (2014) -
Withdrawal of antiepileptic drugs in patients with low grade and anaplastic glioma after long-term seizure freedom: a prospective observational study
por: Kerkhof, M., et al.
Publicado: (2019) -
Is the EORTC QLQ‐C30 emotional functioning scale appropriate as an initial screening measure to identify brain tumour patients who may possibly have a mood disorder?
por: Oort, Quirien, et al.
Publicado: (2022)